MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, WST made $3,074,100K in revenue. $493,700K in net income. Net profit margin of 16.06%.

Income Overview

Revenue
$3,074,100K
Net Income
$493,700K
Net Profit Margin
16.06%
EPS
$6.79
Unit: Thousand (K) dollars
Revenue Breakdown
    • Proprietary Products
    • Contract Manufactured Products
Revenue Breakdown
    • US
    • Other Europe Countries
    • DE
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Net sales
3,074,100 2,893,200 2,949,800 2,886,900
Cost of goods and services sold
1,970,100 1,894,700 1,820,600 1,750,700
Gross profit
1,104,000 998,500 1,129,200 1,136,200
Research and development
74,300 69,100 68,400 58,500
Selling, general and administrative expenses
393,600 338,500 353,400 316,900
Severance and benefits
19,200 -2,500 -8,700
Asset impairments
-7,300 -15,300
Asset-related charges
5,400 0 --
Other charges
-0 --200
Total restructuring and related charges
24,600 -2,500 -23,800
Fixed asset impairments and sale of equipment, net
---2,700
Asset impairments
8,200 ---
(gain) loss on oil hedges
---1,500
Foreign exchange transaction losses
-8,400 -10,200 -4,100
Contingent consideration
8,700 5,100 -3,000
Cost investment activity
----3,500
Loss on disposal of plant
0 0 --
Other items
-1,300 -900 -600
Other expense (income) (note 16)
-51,200 -21,000 -31,400 -26,800
Operating profit
584,900 569,900 676,000 734,000
Interest expense
500 3,000 9,000 7,900
Interest income
17,500 19,600 28,000 5,100
Other nonoperating expense (income)
-1,000 -1,000 3,000 -51,300
Income before income taxes and equity in net income of affiliated companies
600,900 585,500 698,000 679,900
Income tax expense
121,600 107,500 122,300 114,700
Equity in net income of affiliated companies
14,400 14,700 17,700 20,700
Net income
493,700 492,700 593,400 585,900
Basic (in dollars per share)
6.83 6.75 7.98 7.87
Basic (in shares)
72,300,000 73,000,000 74,300,000 74,400,000
Diluted (in dollars per share)
6.79 6.69 7.88 7.73
Diluted (in shares)
72,700,000 73,700,000 75,300,000 75,800,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Contract ManufacturedProducts$582,000K Proprietary Products$2,492,100K Net sales$3,074,100K Gross profit$1,104,000K Cost of goods andservices sold$1,970,100K Interest income$17,500K Operating profit$584,900K Other expense(income) (note 16)-$51,200K Selling, general andadministrative expenses$393,600K Research and development$74,300K Equity in net income ofaffiliated companies$14,400K Income before incometaxes and equity in net...$600,900K Other nonoperatingexpense (income)-$1,000K Interest expense$500K Other items-$1,300K Contingent consideration$8,700K Foreign exchangetransaction losses-$8,400K Asset impairments$8,200K Total restructuringand related charges$24,600K Net income$493,700K Income tax expense$121,600K Asset-related charges$5,400K Severance and benefits$19,200K

WEST PHARMACEUTICAL SERVICES INC (WST)

WEST PHARMACEUTICAL SERVICES INC (WST)